Systems and methods for peripheral nervous stimulation for metabolic and endocrine function

US2017239484A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2017239484-A1
Application numberUS-201715438976-A
CountryUS
Kind codeA1
Filing dateFeb 22, 2017
Priority dateFeb 23, 2016
Publication dateAug 24, 2017
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Systems and methods are provided for neuro stimulation. In one implementation, a system is provided that includes a stimulator introduced into tissue at a target location and a central controller that communicates wirelessly with the stimulator. The stimulator includes a power system that receives wireless energy transmission, and an electrode system that transmits an electrical pulse for stimulating the target location. The central controller includes a power system that wirelessly delivers power to the stimulator, a communication system that wirelessly communicates with the stimulator, and a processing system that controls the power system and the communication system. The central controller may instruct the stimulator to transmit one or more electrical pulses to the target location to affect an endocrine function (e.g., affect the glucose level of a patient).

First claim

Opening claim text (preview).

1 . A system for neuro stimulation, comprising: a micro particle comprising: a power system that receives wireless energy transmission; and an electrode system that transmits an electrical pulse for stimulating the target location; and a central controller comprising: a power system that wirelessly delivers power to the micro particle; a communication system that wirelessly communicates with the micro particle; and a processing system that controls the power system and the communication system; the central controller instructing the micro particle to transmit one or more electrical pulses to the target location to affect an endocrine function of a patient. 2 . The system of claim 1 , further comprising a plurality of micro particles at one or more target locations. 3 . The system of claim 2 , wherein the electrode system includes an electrode that stimulates and senses electrical pulses at each target location. 4 . The system of claim 3 , wherein the micro particle wirelessly transmits informational signals to the central controller indicative of the electrical pulses sensed at the target location. 5 . The system of claim 3 , wherein the central controller executes a stimulation protocol that stimulates the one or more target locations and senses electrical pulses at the one or more target locations. 6 . The system of claim 2 , wherein the plurality of micro particles are uniquely addressable to enable the central controller to communicate with each micro particle individually. 7 . The system of claim 1 , wherein the target location is a sympathetic or parasympathetic neuronal pathway connected to one of the pancreas, the liver, and/or the small intestine. 8 . The system of claim 1 , wherein the target location is the celiac ganglion. 9 . The system of claim 1 , wherein: the endocrine function is a glucose level of the patient; and the system further comprises a glucose sensor that measures the glucose level of the patient as a feedback datum. 10 . The system of claim 9 , wherein the glucose sensor continuously measures the glucose level of the patient. 11 . A system for neuro stimulation, comprising: a stimulator implanted at a target location, the stimulator comprising: a power system that receives wireless energy transmission; and at least one microelectrode system that transmits an electrical pulse for stimulating the target location; and a central controller comprising: a power system that wirelessly delivers power to the at least one microelectrode; a communication system that wirelessly communicates with the at least one microelectrode; and a processing system that controls the power system and the communication system; the central controller instructing the at least one microelectrode to transmit one or more electrical pulses to the target location to affect an endocrine function of a patient. 12 . The system of claim 11 , further comprising a plurality of microelectrodes at one or more target locations. 13 . The system of claim 12 , wherein the at least one microelectrode includes an electrode that stimulates and senses electrical pulses at each target location. 14 . The system of claim 13 , wherein the stimulator wirelessly transmits informational signals to the central controller indicative of the electrical pulses sensed at the target location. 15 . The system of claim 13 , wherein the central controller executes a stimulation protocol that stimulates the one or more target locations and senses electrical pulses at the one or more target locations. 16 . The system of claim 12 , wherein the plurality of microelectrodes are uniquely addressable to enable the central controller to communicate with each microelectrode individually. 17 . The system of claim 11 , wherein the target location is a sympathetic or parasympathetic neuronal pathway connected to one of the pancreas, the liver and/or the small intestine. 18 . The system of claim 11 , wherein the target location is the celiac ganglion. 19 . The system of claim 11 , wherein: the endocrine function is a glucose level of the patient; and the system further comprises a glucose sensor that measures the glucose level of the patient as a feedback datum. 20 . The system of claim 19 , wherein the glucose sensor continuously measures the glucose level of the patient. 21 . The system of claim 11 , wherein the stimulator is a multicontact cuff for targeted stimulation. 22 . The system of claim 11 , further comprising a wireless battery charger for powering the stimulator from outside the body or through wires from an implanted battery operated pulse generator. 23 . The system of claim 11 , further comprising an implanted pulse generator for powering the stimulator through wires. 24 . A method of stimulating an endocrine function of a mammal by neuro stimulation, the method comprising: locating a micro particle at a target location associated with the control of the endocrine function to be stimulated, the micro particle comprising: a power system that receives a wireless energy transmission; and an electrode system that transmits an electrical pulse to the target location; selectively delivering power and signals wirelessly to the micro particle from a central controller, the central controller comprising: a power system that wirelessly delivers power to the micro particles; a communication system that wirelessly communicates with the micro particle; and a processing system that controls the power system and the communication system; and selectively stimulating the target location by transmitting an electrical pulse using the micro particle to stimulate the endocrine function of a patient. 25 . The method of claim 24 , further comprising selectively sensing electrical pulses at the target location using the micro particle. 26 . The method of claim 24 , further comprising selectively distributing a plurality of micro particles at a plurality of target locations. 27 . The method of claim 26 , further comprising executing a stimulation protocol that stimulates the one or more target locations and senses electrical pulses at the one or more target locations. 28 . The method of claim 24 , wherein the target locations is a sympathetic or parasympathetic neuronal pathway connected to one of the pancreas, the liver and/or the small intestine. 29 . The method of claim 24 , wherein the target location is the celiac ganglion. 30 . The method of claim 24 , wherein: the endocrine function is a glucose level of the patient; and the method further comprises monitoring the glucose level of the patient as a feedback datum. 31 . The method of claim 30 , wherein monitoring comprises continuously monitoring the glucose level of the patient. 32 . A method of stimulating an endocrine function of a mammal by neuro stimulation, the method comprising: identifying a likely eating event by the mammal; and stimulating the autonomic system of the mammal to provide an insulin spike at a time prior to an eating event. 33 . A method of stimulating an endocrine function of a mammal by neuro stimulation, the method comprising: identifying at a target location associated with the control of the endocrine function to be stimulated

Assignees

Inventors

Classifications

  • Cuff electrodes · CPC title

  • liver · CPC title

  • Microstimulators, e.g. implantable through a cannula · CPC title

  • Communication to several implantable medical devices within one patient · CPC title

  • adapted for a particular treatment · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2017239484A1 cover?
Systems and methods are provided for neuro stimulation. In one implementation, a system is provided that includes a stimulator introduced into tissue at a target location and a central controller that communicates wirelessly with the stimulator. The stimulator includes a power system that receives wireless energy transmission, and an electrode system that transmits an electrical pulse for stimu…
Who is the assignee on this patent?
Verily Life Sciences Llc
What technology area does this patent fall under?
Primary CPC classification A61N1/37205. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Aug 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).